Calendula officinalis whole
- Generic Name
- Calendula officinalis whole
- Drug Type
- Biotech
- Unique Ingredient Identifier
- PFR03EBU0H
- Background
Calendula officinalis whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Stratpharma AG
- Target Recruit Count
- 344
- Registration Number
- NCT05810194
- Locations
- 🇺🇸
University of California, Los Angeles, California, United States
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
Not Applicable
Withdrawn
- Conditions
- Breast CarcinomaRadiation-Induced DermatitisHead and Neck Carcinoma
- Interventions
- Drug: Silicone-based Film Forming Topical GelOther: Petrolatum-Mineral Oil-Lanolin-Ceresin OintmentOther: Polyethylene Glycol Hydrogel
- First Posted Date
- 2021-10-11
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- OHSU Knight Cancer Institute
- Registration Number
- NCT05073172
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Trial Comparing Calendula Officinalis With Aqueous Cream "Essex" to Treat Skin Reactions From Radiotherapy of Breast Cancer
Phase 3
Completed
- Conditions
- Postoperative Radiotherapy Breast Cancer
- Interventions
- Drug: Essex® cream (Schering-Plough), aqueous cream without parabens
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2015-09-17
- Lead Sponsor
- Karolinska University Hospital
- Target Recruit Count
- 420
- Registration Number
- NCT01688479
- Locations
- 🇸🇪
Department of Oncology, Karolinska University Hospital, Stockholm, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath